| 000 | 01150 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250512224900.0 | ||
| 264 | 0 | _c19840323 | |
| 008 | 198403s 0 0 eng d | ||
| 022 | _a0306-5251 | ||
| 024 | 7 |
_a10.1111/j.1365-2125.1983.tb02239.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBanfield, C | |
| 245 | 0 | 0 |
_aPhenylbutazone-warfarin interaction in man: further stereochemical and metabolic considerations. _h[electronic resource] |
| 260 |
_bBritish journal of clinical pharmacology _cDec 1983 |
||
| 300 |
_a669-75 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHydroxylation |
| 650 | 0 | 4 |
_aMetabolic Clearance Rate _xdrug effects |
| 650 | 0 | 4 |
_aPhenylbutazone _xpharmacology |
| 650 | 0 | 4 | _aStereoisomerism |
| 650 | 0 | 4 |
_aWarfarin _xmetabolism |
| 700 | 1 | _aO'Reilly, R | |
| 700 | 1 | _aChan, E | |
| 700 | 1 | _aRowland, M | |
| 773 | 0 |
_tBritish journal of clinical pharmacology _gvol. 16 _gno. 6 _gp. 669-75 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2125.1983.tb02239.x _zAvailable from publisher's website |
| 999 |
_c6661157 _d6661157 |
||